DOSSIER · UPDATED 18 JUN 2026

Angion Biomedica

Elicio Therapeutics, Inc. operates as a biopharmaceutical company. The Company develops potent lymph node targeted immunotherapies and vaccines to re-engineering the body's immune response to defeat cancer and infectious diseases. Elicio…

elicio.com ↗Claim this profile

Founded: 1998
Headcount: 60
Open roles: 0
Last raised: Post Ipo Equity · $100M

SECTION I · THE BRIEF

Inside Angion Biomedica

Brief #26124Updated 18 JUN 2026UNIONDALEMEDICAL ORGANIZATIONSPOST IPO EQUITY

Employbl Dossier

Angion Biomedica

Elicio Therapeutics, Inc. operates as a biopharmaceutical company. The Company develops potent lymph node targeted immunotherapies and vaccines to re-engineering the body's immune response to defeat cancer and…

Founded: 1998
Headcount: 60
Open roles: 0
Last raised: Post Ipo Equity · $100M

Section II · Premium ProfileMembers only

01Engineering interview process at Angion BiomedicaLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Angion Biomedica brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Darrell Irvine

OPEN ROLES

Hiring at Angion Biomedica

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $448,098,016

Angion Biomedica Funding Rounds

Post Ipo Equity
$100,000,000
Mar 16, 2026
Post Ipo Equity
$10,000,000
Jan 30, 2025
Post Ipo Debt
$20,000,000
Aug 12, 2024
Post Ipo Equity
$11,500,000
Jun 28, 2024
Post Ipo Equity
$7,000,000
Dec 22, 2023
Grant
$2,600,000
Sep 7, 2023
Debt Financing
$10,000,000
Jan 17, 2023
Grant
$2,800,000
Nov 3, 2022
Series C
$37,000,000
May 27, 2022
Debt Financing
$14,470,000
Nov 12, 2021
Series B
$73,000,000
Feb 17, 2021
Post Ipo Equity
$25,000,000
Feb 5, 2021
IPO
Unknown
Jan 1, 2021
Series Unknown
$8,411,801
Mar 13, 2020
Series B
$33,000,000
Oct 2, 2019
Grant
$4,760,000
Apr 3, 2019
Series Unknown
$30,000,000
Mar 29, 2019
Series Unknown
$35,000,000
Jan 4, 2019
Series Unknown
$15,000,000
Jul 17, 2018
Series Unknown
$750,000
May 24, 2016
Series Unknown
$4,356,452
Feb 20, 2015
Grant
$149,761
Dec 11, 2013
Series Unknown
$3,300,000
Aug 3, 2012

Funding info provided by Diffbot.

TAGS

Categorized in

Company Collections

These are collections Angion Biomedica is a part of. Click on the collection name to view similar companies.

Angion Biomedica's Industries

Medical Organizations

Health Care Companies

Biotechnology Companies

LOCATIONS

Where they work

Angion Biomedica Headquarters Location

51 Charles Lindbergh Boulevard, Uniondale, NY, 11553-3658

Loading map…